I'm joined this week by Charlie Petty, a managing director at the Global Health Investment Corporation. GHIC is a venture capital fund with the unusual thesis that there are profitable investments to be made in companies developing diagnostics and treatments for markets in the developing world.

We talk about what makes his job harder (and easier) than conventional biotech VC, which clinical trials cost an order of magnitude (or more!) less than you'd expect, and the looming rise of a “less unipolar” biotech world.

Full transcript at https://developmentandresearch.bio/episode/charlie-petty/